Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

novo nordisk a/s - glukagon - prašek in vehikel za raztopino za injiciranje - glukagon 1 mg / 1 ml - glukagon

Evropska unija - slovenščina - EMA (European Medicines Agency)

eli lilly nederland b.v. - glukagon - sladkorna bolezen - trebušne slinavke hormonov, glycogenolytic hormonov - baqsimi je primerna za zdravljenje hude hypoglycaemia pri odraslih, mladostnikih in otrocih, starih 4 leta in več, s sladkorno boleznijo.

Evropska unija - slovenščina - EMA (European Medicines Agency)

tetris pharma b.v - glukagon - sladkorna bolezen - trebušne slinavke hormonov, glycogenolytic hormonov - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.

Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).

Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin; vildagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin; vildagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

belupo, lijekovi i kozmetika, d.d. - vildagliptin - tableta - vildagliptin 50 mg / 1 tableta - vildagliptin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

vildagliptin - tableta - vildagliptin 50 mg / 1 tableta - vildagliptin